Nermin Gündüz

Nermin Gündüz

Auto-generated profile, based on publicly available information

Nermin Gündüz

Department of Pathology, University of Health Sciences, Kanuni Sultan Süleyman Training and Research Hospital, İstanbul, Türkiye

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2013 in Gynecologic and Obstetric Investigation
Verified
Journal Article
Closed access
PDF file
AEAytul Corbacioglu Esmer
Aytul Corbacioglu Esmer
OAOzgur Akbayir
Ozgur Akbayir
BGBehiye Pinar Cilesiz Goksedef
Behiye Pinar Cilesiz Goksedef
NGNermin Gunduz
Nermin Gunduz
SKSongul Kisacık
Songul Kisacık
CACemal Ark
Cemal Ark
Aim: To determine a cutoff age for endometrial evaluation in premenopausal abnormal uterine bleeding (AUB). Methods: Histopathology reports of endometrial sampling performed due to AUB in women aged 50 years or less were reviewed retrospectively. Histopathological findings were categorized into three groups as follows: group 1: hyperplasia without atypia + hyperplasia with atypia + malignancy, group 2: hyperplasia with atypia + malignancy, and group 3: malignancy. Results: Data from 2,516 patients were analyzed for this study. Overall, 13.5% of patients had endometrial hyperplasia without atypia, 1% of patients had hyperplasia with atypia and 0.6% of patients had malignant disease. Logistic regression revealed a significant difference in the odds ratios of group 1 in the age ranges of 40-45 and 45-50 years compared with <40 years (p = 0.001 and p = 0.01, respectively). There were no significant differences between the age groups for the odds ratio of group 2 and group 3. Conclusion: There is no cutoff age for sampling the endometrium in order to detect hyperplasia with atypia and cancer in premenopausal women with AUB. Therefore, the management of AUB should be tailored to each patient regardless of age, incorporating all risk factors for malignant disease.

8 July 2024 in Joint Diseases and Related Surgery
Verified
Journal Article
Open access
TSTahir Burak Sarıtaş
Tahir Burak Sarıtaş
CECemil Ertürk
Cemil Ertürk
HBHalil Büyükdoğan
Halil Büyükdoğan
BYBurak Yıldırım
Burak Yıldırım
NGNermin Gündüz
Nermin Gündüz
ŞSŞahabettin Selek
Şahabettin Selek
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.

24 October 2019 in Istanbul Medical Journal
Verified
Journal Article
Closed access
NONihan İlHan Oruç
Nihan İlHan Oruç
HCHale Goksever Celik
Hale Goksever Celik
NGNermin Gündüz
Nermin Gündüz
GYGökhan Yıldırım
Gökhan Yıldırım

5 January 2022 in Acta Chirurgica Belgica
Verified
Journal Article
Closed access
TATansu Altintaş
Tansu Altintaş
NÖN. Berrin Dodur Önalan
N. Berrin Dodur Önalan
MKMehmet Celal Kızılkaya
Mehmet Celal Kızılkaya
NGNermin Gündüz
Nermin Gündüz
MBMehmet Abdussamet Bozkurt
Mehmet Abdussamet Bozkurt
There is no clear consensus as to which topical hemostatic agent is best used during cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. The aim of this study was to evaluate the effect of hyperthermic chemotherapy on the biomechanical properties of organic topical hemostatic agents and histologically fibrin formation rates. Four topical hemostatic agents (Spongostan™, Surgicel®, Fibrillar™, Arista®) were evaluated. All agents were mixed with 3 ml blood in sterile tubes separately to form clot formation. The resulting clot formations were incubated with 36 °C and 42 °C with saline or cisplatin for 1 h. Strength and flexibility of hemostatic samples were evaluated under weight of 0 g, 50 g, 100 g, 200 g and 300 g. All samples were stained with hemotoxylin-eosin and compared histologically for fibrin clot formation under light microscope. There were no statistically significant differences according to strength and flexibility of topical hemostatic agents on hyperthermic chemotherapy. Histopathologically, the highest fibrin formation was observed in Surgicel®, followed by Fibrillar™. The least fibrin formation was detected in Arista®. This study demonstrated that exposure to hyperthermic chemotherapy did not significantly affect the biomechanical properties of organic topical hemostatic agents and the fibrin clot formation.

1 December 2015 in İstanbul Kanuni Sultan Süleyman Tıp dergisi
Verified
Journal Article
Closed access
KSKerem Doğa Seçkin
Kerem Doğa Seçkin
MKMehmet Fatih Karslı
Mehmet Fatih Karslı
BYBurak Yücel
Burak Yücel
MKMeriç Kabakçı
Meriç Kabakçı
PKPınar Kadiroğulları
Pınar Kadiroğulları
GYGökhan Yıldırım
Gökhan Yıldırım